Squamous cell carcinoma of the scrotum

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Squamous cell carcinoma of the scrotum still has a poor prognosis. However, patients with stage A1 disease have approximately a 75 per cent chance for long-term survival. Occupational-related and induced scrotal carcinomas are less frequent now because of better hygiene, protective clothing and awareness of the carcinogenity of industrial oils. The basic treatment for squamous cell carcinoma of the scrotum still depends upon wide local excision of the primary lesion. Before sentinel node biopsy or ilioinguinal lymphadenectomy patients should be treated with 4 to 6 weeks of antibiotics. Sentinel and superficial node biopsy should be done to rule out micrometastasis as well as to prove the need for ilioinguinal lymphadenectomy. Radiation therapy has little therapeutic benefit in the treatment of patients with squamous cell carcinoma of the scrotum. Bleomycin might be useful as adjuvant therapy for widespread ilioinguinal disease before attempted resection, although this has yet to be proved.

Original languageEnglish (US)
Pages (from-to)423-427
Number of pages5
JournalJournal of Urology
Issue number3
StatePublished - 1983
Externally publishedYes

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Squamous cell carcinoma of the scrotum'. Together they form a unique fingerprint.

Cite this